• Vitamin K2 Mitigates Osteoblast Ferroptosis in GIOP via NRF2

  2026-07-15

  Zhang et al. demonstrate that vitamin K2 protects against glucocorticoid-induced osteoporosis by activating the NRF2/FSP1 pathway, thereby inhibiting ferroptosis in osteoblasts. These findings clarify a mechanistic link between oxidative stress, ferroptosis, and bone health, suggesting new therapeutic strategies for secondary osteoporosis.

• Orientia tsutsugamushi Alters RIPK3 but Fails to Block Necro

  2026-07-15

  This study investigates how Orientia tsutsugamushi, the causative agent of scrub typhus, interacts with host cell death pathways. By demonstrating that Orientia reduces cellular RIPK3 levels without inhibiting necroptosis once triggered, the research advances our understanding of host-pathogen interactions and the limits of bacterial modulation of programmed cell death.

• BPN-19186: Mechanistic Insights into sEH-Nrf2 Signaling Modu

  2026-07-14

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) is a high-purity, research-grade inhibitor for signaling pathway and enzyme inhibition studies. Its validated application in modulating sEH-Nrf2 signaling provides precise tools for osteoporosis and redox biology research. The compound’s robust solubility profile and documented efficacy support reproducible experimental design.

• Protease Inhibitor Cocktail EDTA-Free: Innovations in Protei

  2026-07-14

  Explore how the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) delivers unmatched protein preservation for phosphorylation-sensitive assays. This in-depth article examines the science, practical protocol insights, and unique considerations that set it apart.

• 6-Thioguanine Inhibits EV71 by Targeting BIRC3-Mediated Auto

  2026-07-13

  This study reveals that 6-thioguanine efficiently blocks EV71 replication by downregulating BIRC3-mediated autophagy pathways in vitro. The mechanistic insights offer a potential therapeutic direction for hand, foot, and mouth disease, highlighting 6-thioguanine's unique antiviral mechanism beyond its established anticancer and immunosuppressive uses.

• Birinapant (TL32711): Applied Protocols for Apoptosis Resear

  2026-07-13

  Birinapant (TL32711) delivers precise, robust inhibition of IAPs, enabling researchers to probe apoptosis resistance and synergize with chemoradiotherapy sensitivity biomarkers like MDM1. This article translates cutting-edge evidence into actionable workflows, troubleshooting, and assay optimization for translational cancer research.

• Fosinopril Sodium (SKU A4079): Reliable ACE Inhibitor for La

  2026-07-12

  This article provides scenario-driven guidance for biomedical researchers and technicians navigating ACE inhibition assays, cell viability workflows, and cardiovascular modeling. Using Fosinopril sodium (SKU A4079), we address reproducibility, pharmacokinetic advantages, and reliable vendor selection, highlighting its scientific merits and practical benefits for laboratory applications.

• Meropenem Trihydrate: Evidence-Based Profile of a Carbapenem

  2026-07-10

  Meropenem trihydrate is a broad-spectrum carbapenem antibiotic with potent activity against gram-negative, gram-positive, and anaerobic bacteria. It exhibits low MIC90 values and robust resistance to β-lactamase hydrolysis, making it a gold-standard agent for antibacterial and resistance phenotyping research. APExBIO’s B1217 product offers high solubility and validated stability for reproducible experimental workflows.

• Phosbind Acrylamide: Precision Phosphate-Binding in SDS-PAGE

  2026-07-09

  Phos binding reagent (Phosbind) acrylamide revolutionizes protein phosphorylation analysis by enabling antibody-free, high-resolution separation of phospho-isoforms in SDS-PAGE. Its robust, MnCl2-mediated phosphate-binding chemistry unlocks new workflows for dissecting signal transduction and viral host interactions, making it indispensable for advanced cellular stress and kinase pathway research.

• Perospirone (SM-9018) in Translational Schizophrenia Models

  2026-07-09

  Perospirone (SM-9018 freebase) is a potent, dual 5-HT2A/D2 antagonist and 5-HT1A partial agonist, widely used in schizophrenia research. New evidence highlights its off-target inhibition of vascular Kv1.5 channels, presenting both opportunities and considerations for translational researchers. This article provides mechanistic insights, protocol recommendations, and strategic guidance on leveraging Perospirone in neuropsychiatric and cardiovascular research models, while also addressing its unique experimental and clinical implications.

• Exercise-Induced Muscle Vesicles Enhance Microglial Amyloid

  2026-07-08

  This study uncovers how swimming exercise in Alzheimer’s disease (AD) mouse models boosts the secretion of skeletal muscle-derived extracellular vesicles (SKM-EVs), which are taken up by microglia to promote amyloid-beta plaque clearance. The findings reveal miR-378a-3p as a key vesicle cargo driving microglial lipid metabolic changes, offering mechanistic insight and potential translational strategies for AD intervention.

• Protease Inhibitor Cocktail EDTA-Free: Precision for Protein

  2026-07-08

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO is a broad-spectrum protein extraction protease inhibitor that preserves protein structure during cell and tissue disruption. Its EDTA-free formulation is specifically compatible with phosphorylation analysis and sensitive enzymatic assays. This article details the rationale, mechanisms, evidence, and workflow integration for this reagent.

• PTX3 Mitigates Steroid-Induced Bone Necrosis via TLR4/NF-κB-

  2026-07-07

  This study reveals that pentraxin 3 (PTX3) counteracts glucocorticoid-induced osteonecrosis of the femoral head by modulating the TLR4/NF-κB-FGF21 signaling axis. The findings provide mechanistic insight into steroid-related bone disease and identify PTX3 as a potential therapeutic target.

• IRG1-Itaconic Acid Axis Regulates TBK1 and Type I IFN Respon

  2026-07-07

  Chai et al. uncover a metabolic feedback mechanism where the IRG1-itaconic acid pathway alkylates TBK1 at Cys605, limiting excessive type I interferon responses. Their work connects energy metabolism to innate immunity and introduces itaconate-based TBK1 inhibitors as candidates for controlling hyperinflammation.

• Protease Inhibitor Cocktail: Precision in Protein Extraction

  2026-07-06

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) delivers robust, phosphorylation-compatible protection against protein degradation during extraction and analysis. Its unique formulation supports advanced workflows—such as kinase assays and in vitro genotoxicity studies—where conventional inhibitors may impede critical downstream steps.

16779 records 1/1119 page Next 12345 下5页 Last page